
According to official data, the government’s production-linked incentive (PLI) system had the largest gains in the fiscal year 2024–2025, with the electronics and pharmaceutical industries accounting for approximately 70% of the total reward granted.
According to the data, the electronics industry received INR 5,732 crore of the INR 10,114 crore distributed under the scheme during the year, while the pharmaceutical sector received INR 2,328 crore. The PLI program was first implemented for 14 important sectors in 2021 with the goal of promoting domestic production.
Since then, it has been instrumental in bolstering India’s industrial base and promoting exports with greater value added. The performance of the electronics industry amply demonstrates the scheme’s effectiveness.
Electronics are now among India’s top three export categories as a result of the robust manufacturing push. Shipments increased from $29.12 billion in 2023–2024 to $38.58 billion in the prior fiscal year, indicating a noteworthy export growth of 32.46% in 2024–2025.
According to government figures, this represents a significant increase from $15.7 billion in 2021–2022 to $23.6 billion in 2022–2023. A significant feature of the electronics segment was the remarkable 101% rise in computer hardware and peripherals, with exports tripling from $0.7 billion to $1.4 billion in FY25.
Top destinations for Indian electronic items included the United States, the Netherlands, the United Kingdom, Italy, and the United Arab Emirates. The pharmaceutical industry also kept up its impressive performance. Currently, more than 200 countries are receiving pharmaceutical products and medications from India.
Pharma exports increased by over 10% to $30.5 billion in 2024–2025, demonstrating the nation’s global leadership in the pharmaceutical and healthcare industries.
The new data shows how the PLI scheme is increasingly influencing India’s manufacturing and export goals, particularly in industries where the nation is starting to take the lead internationally.


Leave a Reply